文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
The Additional Costs per Month of Progression-Free Survival and Overall Survival: An Economic Model Comparing Everolimus with Cabozantinib, Nivolumab, and Axitinib for Second-Line Treatment of Metastatic Renal Cell Carcinoma
复制论文ID
分享
摘要
作者
参考文献
暂无分享,去
创建一个
E. Swallow
|
A. Messali
|
E. Duchesneau
|
S. Ghate
|
J. Pérez
|
E. McDonald
保存到论文桶